02655nam 2200493 450 991048496960332120210324150349.03-030-57369-910.1007/978-3-030-57369-0(CKB)4100000011665211(DE-He213)978-3-030-57369-0(MiAaPQ)EBC6427443(PPN)252518705(EXLCZ)99410000001166521120210324d2021 uy 0engurnn|008mamaatxtrdacontentcrdamediacrrdacarrierCannabinoids and neuro-psychiatric disorders /Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti, editors1st ed. 2021.Cham, Switzerland :Springer,[2021]©20211 online resource (XVII, 153 p. 43 illus., 4 illus. in color.) Advances in experimental medicine and biology ;Volume 12643-030-57368-0 This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues. Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (Δ9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among other effects. Despite these undesirable effects, signaling is mostly inhibitory and suggests a putative role for cannabinoids as therapeutic agents by managing several diseases where inhibition of neurotransmitter release would be beneficial. The themes of this book have been edited and written by world-leaders in the field, The contents of the volume aims at readers from a range of academic and professional disciplines, such as biomedicine, several areas of biology, neurology, clinical medicine and pharmacy.Advances in experimental medicine and biology ;Volume 1264.CannabinoidsMolecular biologyCannabinoids.Molecular biology.615.7827Murillo-Rodríguez EricPandi-Perumal S. R.Monti Jaime M.MiAaPQMiAaPQMiAaPQBOOK9910484969603321Cannabinoids and neuro-psychiatric disorders2804499UNINA